Literature DB >> 19947784

Momentary assessment research in psychosis.

Margreet Oorschot1, Thomas Kwapil, Philippe Delespaul, Inez Myin-Germeys.   

Abstract

There is an expanding interest to study psychosis in the realm of daily life. The study of the person in the context of daily life may provide a powerful addition to more conventional and cross-sectional research strategies in the study of psychosis. This article first discusses the nature of experience sampling research in psychosis and demonstrates the feasibility and validity of studies using the experience sampling method (ESM) in this patient group. Second, the article presents a review of all ESM research in psychosis with a special focus on (a) the phenomenology, (b) the etiology, and (c) psychological models of psychosis. Variability over time and the dynamic interplay with the environment were found to be essential features of the positive symptoms of psychosis, whereas behavioral patterns as well as self-reported affect in daily life reality might be essential when studying negative symptomatology. ESM contributes to a better understanding of the interplay between psychotic experiences and environmental features, such as stress or cannabis exposure. Finally, the study of symptomatic variability may fuel new research into psychological models and treatment of psychosis and the study of the person-environment interplay may foster new Gene x Environment interaction studies.

Entities:  

Mesh:

Year:  2009        PMID: 19947784     DOI: 10.1037/a0017077

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  34 in total

1.  Future in psychopathology research.

Authors:  Stephan Heckers
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

2.  Do child abuse and maltreatment increase risk of schizophrenia?

Authors:  Lucia Sideli; Alice Mule; Daniele La Barbera; Robin M Murray
Journal:  Psychiatry Investig       Date:  2012-04-30       Impact factor: 2.505

3.  Mobile assessment in schizophrenia: a data-driven momentary approach.

Authors:  Margreet Oorschot; Tineke Lataster; Viviane Thewissen; Marieke Wichers; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2011-11-29       Impact factor: 9.306

4.  Comparing experiential acceptance and cognitive reappraisal as predictors of functional outcome in individuals with serious mental illness.

Authors:  Roger Vilardaga; Steven C Hayes; David C Atkins; Christie Bresee; Alaei Kambiz
Journal:  Behav Res Ther       Date:  2013-05-02

5.  Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.

Authors:  Emma E M Knowles; Samuel R Mathias; Godfrey D Pearlson; Jennifer Barrett; Josephine Mollon; Dominique Denbow; Katrina Aberzik; Molly Zatony; David C Glahn
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

Review 6.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

Review 7.  Ambulatory assessment.

Authors:  Timothy J Trull; Ulrich Ebner-Priemer
Journal:  Annu Rev Clin Psychol       Date:  2012-11-13       Impact factor: 18.561

8.  Using experience sampling methods/ecological momentary assessment (ESM/EMA) in clinical assessment and clinical research: introduction to the special section.

Authors:  Timothy J Trull; Ulrich W Ebner-Priemer
Journal:  Psychol Assess       Date:  2009-12

9.  Planned missing-data designs in experience-sampling research: Monte Carlo simulations of efficient designs for assessing within-person constructs.

Authors:  Paul J Silvia; Thomas R Kwapil; Molly A Walsh; Inez Myin-Germeys
Journal:  Behav Res Methods       Date:  2014-03

10.  Ecological Momentary Assessment of social functioning in schizophrenia: impact of performance appraisals and affect on social interactions.

Authors:  Eric Granholm; Dror Ben-Zeev; Daniel Fulford; Joel Swendsen
Journal:  Schizophr Res       Date:  2013-02-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.